Both cannabis stocks have had a rough go of it of late. Which has the best shot at turning things around?
News & Analysis: Medical Marijuana, Inc.
Some marijuana stocks are worth a serious look. These aren't.
These were the only three pot stocks to advance by a double-digit percentage in May.
Acquisitions can be a double-edged sword for even the most popular pot stocks.
Two of the most popular marijuana stocks face-planted last month.
Dig beneath its rapid sales growth, and you'll find good reason why this pot stock is down 19% since the year began.
With global CBD sales potentially hitting $22 billion by 2022, here are four CBD stocks you'll want to know about.
The green rush went up in smoke for shareholders in these five marijuana stocks.
Which of these two pioneering cannabis plays is the better buy right now?
There are better stocks in the hemp-derived CBD space -- including Canopy Growth.